WC
GILD icon

Whitney & Co’s Gilead Sciences GILD Stock Holding History

Whitney & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-56,251
Closed -$3.63M – 129
2021
Q1 		$3.63M Buy
56,251
+1,318
+2% +$85K 0.64% 49
2020
Q4 		$3.66M Sell
54,933
-1,259
-2% -$76K 0.59% 53
2020
Q3 		$3.55M Buy
56,192
+970
+2% +$67.3K 0.67% 49
2020
Q2 		$4.25M Buy
55,222
+2,888
+6% +$221K 0.87% 45
2020
Q1 		$3.91M Buy
52,334
+1,385
+3% +$95.7K 0.97% 43
2019
Q4 		$3.31M Sell
50,949
-725
-1% -$47.2K 0.66% 54
2019
Q3 		$3.37M Buy
51,674
+2,234
+5% +$146K 0.7% 54
2019
Q2 		$3.34M Buy
49,440
+530
+1% +$34.9K 0.75% 53
2019
Q1 		$3.18M Buy
48,910
+2,497
+5% +$166K 0.72% 52
2018
Q4 		$3.25M Sell
46,413
-3,543
-7% -$248K 0.83% 46
2018
Q3 		$3.59M Buy
49,956
+2,211
+5% +$167K 0.86% 50
2018
Q2 		$3.38M Buy
47,745
+3,491
+8% +$247K 0.9% 51
2018
Q1 		$3.34M Buy
44,254
+3,387
+8% +$269K 0.95% 50
2017
Q4 		$2.93M Buy
40,867
+1,402
+4% +$106K 0.85% 49
2017
Q3 		$2.79M Hold
39,465
– – 0.94% 47
2017
Q2 		$2.79M Sell
39,465
-3,170
-7% -$211K 0.92% 48
2017
Q1 		$2.9M Buy
42,635
+1,570
+4% +$110K 1.05% 45
2016
Q4 		$2.94M Sell
41,065
-8,985
-18% -$668K 1.11% 41
2016
Q3 		$3.96M Buy
50,050
+4,215
+9% +$342K 1.59% 23
2016
Q2 		$3.82M Buy
45,835
+3,610
+9% +$320K 1.55% 22
2016
Q1 		$3.88M Buy
42,225
+4,815
+13% +$434K 1.66% 21
2015
Q4 		$3.79M Buy
37,410
+2,650
+8% +$276K 1.65% 20
2015
Q3 		$3.41M Buy
34,760
+1,840
+6% +$204K 1.54% 22
2015
Q2 		$3.85M Buy
32,920
+3,485
+12% +$381K 1.68% 15
2015
Q1 		$2.89M Buy
29,435
+3,285
+13% +$334K 1.29% 36
2014
Q4 		$2.46M Buy
26,150
+1,300
+5% +$134K 1.11% 42
2014
Q3 		$2.65M Sell
24,850
-500
-2% -$49K 1.22% 42
2014
Q2 		$2.1M Buy
+25,350
New +$1.97M 0.97% 44

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Whitney & Co's GILD Position: Q2 2021 in Review

Whitney & Co sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 56,251 shares — an estimated $3.63M sold.

Whitney & Co first reported a position in GILD in Q2 2014 and held it in 28 quarters. The position peaked at $4.25M in Q2 2020. 1,545 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • Whitney & Co reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
  • Whitney & Co sold 56,251 Gilead Sciences shares in Q2 2021, an estimated $3.63M.
  • Whitney & Co first reported a position in Gilead Sciences in Q2 2014 and held it in 28 quarters.
  • Whitney & Co's Gilead Sciences position peaked at $4.25M in Q2 2020.
  • 1,545 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on Whitney & Co's 13F filing for Q2 2021, filed 13 Aug 2021.